Phase 2
N=45
Inulin and S. Salivarius Reduce Halitosis
Halitosis · Tongue Diseases
Bottom Line
View on ClinicalTrials.gov: NCT02794766 ↗Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Aug 2020
Primary outcome: Primary: Halitosis Measured by Organoleptic Test — 3.2; 3.2; 2.9; 1.4 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Inulin+SS (Drug); S salivarius (Drug); Placebo (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Universidade de Passo Fundo
- Primary completion
- May 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Halitosis Measured by Organoleptic Test |
3.2; 3.2; 2.9; 1.4; 1.8; 1.7 | — |
| PRIMARY Coating Index |
2.2; 2.1; 2.0; 1.3; 1.7; 1.4 | — |
| PRIMARY Halitosis Measured by Halimeter |
181; 197; 187; 100; 125; 149 | — |
| SECONDARY Oral-health Related Quality of Life |
8.8; 5.7; 6.7; 5.6; 4.9; 6.6 | — |
Summary
Halitosis associated with tongue coating results from the production of volatile sulfur compounds by bacterial action. The use of prebiotics and probiotics might be useful in treating such condition. The aim of this study was to evaluate the effect of the prebiotic inulin combined with the probiotic Streptococcus salivarius (SS) on halitosis by coating.
Eligibility Criteria
Inclusion Criteria
- adult patients with halitosis by tongue coating;
- participants must accept to participate in the study;
- tongue coating identified by oral examination;
- halitosis must be confirmed by the organoleptic test.
Exclusion Criteria
- halitosis for other conditions, including periodontal diseases and non-oral conditions;
- use of antibiotics in the last 30 days;
- active smoking (>10 cigarettes/day);
- alcohol consumption (>2 drinks/day);
- report of pregnancy or breastfeeding;
- report of systemic diseases, including diabetes, kidney failure and hepatic cirrhosis.
Data sourced from ClinicalTrials.gov (NCT02794766). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.